GNH USA

Europe — EMA

Linagliptin/Metformin Hydrochloride Rowex (Metformin Hydrochloride, Linagliptin)

GNH USA supplies Linagliptin/Metformin Hydrochloride Rowex (Linagliptin/Metformin), a DPP‑4 inhibitor and biguanide for type 2 diabetes management.

Metformin Hydrochloride, Linagliptin

Request sourcing

1
Pack/s

What is Metformin Hydrochloride, Linagliptin?

Linagliptin/Metformin Hydrochloride, the active ingredient in Linagliptin/Metformin Hydrochloride Rowex, is a DPP‑4 inhibitor; biguanide presented as an oral tablet for systemic use. It is indicated for the management of type 2 diabetes mellitus in adult patients, used as part of a comprehensive glycemic control plan.

GNH USA supplies Linagliptin/Metformin Hydrochloride Rowex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards.

What is Metformin Hydrochloride, Linagliptin used for?

Linagliptin/Metformin Hydrochloride is used within the antidiabetic drug class to improve glycaemic control in type 2 diabetes mellitus.

- Type 2 diabetes mellitus (initial therapy): reduces fasting and post‑prandial glucose levels when combined with diet and exercise. - Type 2 diabetes mellitus (add‑on therapy): provides additional HbA1c reduction when metformin alone does not achieve target levels. - Type 2 diabetes mellitus (combination therapy): supports overall glycaemic management as part of a multi‑drug regimen alongside other antidiabetic agents.

What are the side effects of Metformin Hydrochloride, Linagliptin?

Adverse reactions may occur with Linagliptin/Metformin Hydrochloride and are categorized by frequency.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhoea: loose stools, often transient. - Abdominal discomfort: cramping or pain. - Headache: mild to moderate intensity. - Dizziness: occasional light‑headedness. - Upper respiratory tract infection: mild cold‑like symptoms.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic complication. - Severe hypoglycaemia: especially when combined with insulin or sulfonylureas. - Acute pancreatitis: sudden abdominal pain with elevated enzymes. - Renal impairment: worsening kidney function. - Allergic reactions: rash, angioedema, or anaphylaxis. - Hepatotoxicity: abnormal liver function tests.

What precautions apply to Metformin Hydrochloride, Linagliptin?

When prescribing Linagliptin/Metformin Hydrochloride, clinicians should consider several safety aspects.

- Renal function assessment: evaluate eGFR before initiation and periodically thereafter. - Lactic acidosis risk: avoid in patients with severe renal impairment or hepatic disease. - Hypoglycaemia monitoring: increase vigilance when used with insulin or sulfonylureas. - Pregnancy and lactation: prescribe only if potential benefits outweigh risks. - Drug‑interaction review: assess concomitant medications for possible interactions. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture.

What does Metformin Hydrochloride, Linagliptin interact with?

Linagliptin/Metformin Hydrochloride may interact with other medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Insulin or sulfonylureas: heightened risk of hypoglycaemia. - Iodinated contrast agents: may precipitate renal dysfunction with metformin. - Strong CYP3A4 inhibitors (e.g., ketoconazole): increase linagliptin exposure.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and potassium levels. - Beta‑blockers: can mask symptoms of hypoglycaemia.

Frequently asked questions

What is Linagliptin/Metformin Hydrochloride Rowex used for?+
Linagliptin/Metformin Hydrochloride Rowex is an oral antidiabetic medication indicated for the treatment of type 2 diabetes mellitus in adults. It is used to improve glycaemic control when combined with diet and exercise, either as initial therapy or as an add‑on to other glucose‑lowering agents.
How does Linagliptin work in this combination?+
Linagliptin selectively blocks the enzyme dipeptidyl peptidase‑4 (DPP‑4), which results in higher levels of the incretin hormones GLP‑1 and GIP. These hormones increase insulin secretion and reduce glucagon release in a glucose‑dependent manner, helping to lower blood sugar.
What is the usual dose of Linagliptin/Metformin Hydrochloride Rowex?+
The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Linagliptin/Metformin safe during pregnancy or breastfeeding?+
Safety in pregnancy and lactation has not been fully established. The medication should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by the treating physician.
How do I order Linagliptin/Metformin Hydrochloride Rowex from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does this product compare with other antidiabetic options?+
Linagliptin/Metformin combines a DPP‑4 inhibitor with a biguanide, offering complementary mechanisms: enhanced insulin secretion and reduced hepatic glucose production. Compared with sulfonylureas, it carries a lower risk of hypoglycaemia, and unlike some other DPP‑4 inhibitors, linagliptin does not require dose adjustment in renal impairment.
What are the storage and handling requirements for this medication?+
The product should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the tablets out of reach of children and do not use after the expiry date.
How is Linagliptin/Metformin Hydrochloride Rowex administered?+
It is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless otherwise directed by a healthcare professional.
What are the most serious risks associated with this medication?+
The most serious risks include lactic acidosis (particularly in patients with severe renal or hepatic impairment), severe hypoglycaemia when combined with insulin or sulfonylureas, and rare cases of acute pancreatitis. Patients should be educated to recognize symptoms and seek immediate medical attention if they occur.
Who should not use Linagliptin/Metformin Hydrochloride Rowex?+
Patients with known hypersensitivity to linagliptin, metformin, or any excipients should avoid the product. It is also contraindicated in individuals with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and those with a history of lactic acidosis.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Metformin Hydrochloride, Linagliptin
Route
Oral Use
Manufacturer
Rowex Ltd
Origin
EU

Related products

Autnami

Autnami

Metformin Hydrochloride, Linagliptin

Sandoz D.O.O.
EU
Autnami

Autnami

Metformin Hydrochloride, Linagliptin

Sandoz Pharmaceuticals D.D.
EU
Autnami

Autnami

Metformin Hydrochloride, Linagliptin

Sandoz Pharmaceuticals D.D.
EU
Autnami

Autnami

Metformin Hydrochloride, Linagliptin

Sandoz Pharmaceuticals D.D.
EU